We hope for a better future of Neuroscience in Ukraine

The overarching goal of the NEUROTWIN proposal is to re-establish the Bogomoletz Institute of Physiology (BIPH) in Kiev, Ukraine as an international centre for excellence in Cellular and Molecular Neuroscience.
This goal is set against a sound background of the existing infrastructure, intellectual traditions and the highly educated manpower. That is the adherence to modern procedures and international research environment which all have to be strengthened to achieve the European dimension and to integrate the Institute into European networks.
POTENTIAL
We shall capitalise on the existing potential of international networking for excellence in Cellular and Molecular Neuroscience research, through knowledge transfer and exchange of best practice between BIPH and leading institutions from the UK, Austria, Portugal, Sweden and Germany. The specific objectives of the proposal target several key areas. They include implementing modern research approaches to scientific excellence and innovation capacity of BIPH via infrastructural changes, large scale knowledge transfer between partners, increasing competitiveness of the BIPH researchers in fundraising from international grant bodies.
QUALITY
The quality of the scientific output of BIPH will be improved through continuous training of research staff in academic writing and boosting the quality of post-graduate education. NEUROTWIN will help to boost communication with the policy makers and relevant stakeholders in Ukraine to advocate the importance of neuroscience and neurology research for the improvement of public health and biomedical education.Our managers are always ready to answer your questions. You can call us at the weekends and at night. Also you can visit our office for personal consultation.
ENCOURAGEMENT
NEUROTWIN will step up and stimulate the scientific excellence and innovation capacity in the field of Cellular and Molecular Neuroscience, as well as strengthening scientific collaboration and international standing of the partners involved.
NEUROTWIN
RECENT NEWS
Show more